Susquehanna International Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.92M Buy
+25,400
New +$2.88M 0.69% 15
2024
Q1
Sell
-11,462
Closed -$1.16M 60
2023
Q4
$1.16M Buy
+11,462
New +$1.11M 0.84% 25
2021
Q1
Sell
-118,837
Closed -$11.2M 31
2020
Q4
$11.2M Buy
+118,837
New +$10.4M 8.15% 3
2020
Q2
Sell
-17,105
Closed -$1.48M 92
2020
Q1
$1.41M Buy
+17,105
New +$1.53M 0.57% 36
2019
Q4
Sell
-78,195
Closed -$6.79M 95
2019
Q3
$6.79M Buy
+78,195
New +$7.02M 1.48% 21
2019
Q2
Sell
-97,282
Closed -$8.23M 94
2019
Q1
$8.38M Buy
97,282
+25,496
+36% +$2.05M 2.06% 14
2018
Q4
$5.52M Buy
+71,786
New +$5.59M 4.32% 7

Other funds holding NVS

Susquehanna International Securities's NVS Position: Q3 2024 in Review

Susquehanna International Securities opened a new position in Novartis (NVS) in Q3 2024: 25,400 shares worth $2.92M. The stake represents 0.69% of the portfolio and ranks #15 among its holdings. This is a return to the name: Susquehanna International Securities previously reported a position in NVS as recently as Q4 2023.

Susquehanna International Securities first reported a position in NVS in Q4 2018 and has held it in 7 quarters since. The position peaked at $11.2M in Q4 2020. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Susquehanna International Securities held 25,400 shares of Novartis worth $2.92M as of Q3 2024.
  • Novartis was a new Susquehanna International Securities position in Q3 2024.
  • Novartis made up 0.69% of Susquehanna International Securities's portfolio in Q3 2024, its #15 holding.
  • Susquehanna International Securities first reported a position in Novartis in Q4 2018 and has held it in 7 quarters since.
  • Susquehanna International Securities's Novartis position peaked at $11.2M in Q4 2020.
  • 1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Susquehanna International Securities's 13F filing for Q3 2024, filed 14 Nov 2024.